Atlas Trials

Regor Pharmaceuticals Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Regor Pharmaceuticals Inc.

RecordFirmDate
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors (NCT07524322)Regor Pharmaceuticals Inc.2026-06-01
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (NCT06867718)Regor Pharmaceuticals Inc.2025-01-24
A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities (NCT06277934)Regor Pharmaceuticals Inc.2024-03-08
A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors (NCT06299124)Regor Pharmaceuticals Inc.2023-04-17
A Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors (NCT05764915)Regor Pharmaceuticals Inc.2023-02-15
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes (NCT05297045)Regor Pharmaceuticals Inc.2022-03-29
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer (NCT05304962)Regor Pharmaceuticals Inc.2022-03-04

Track Regor Pharmaceuticals Inc. automatically

Every clearance here is in the API, with alerts when new ones post.